{"id":"W2138973020","doi":"10.1136/bjophthalmol-2013-303232","title":"Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme","year":2013,"lang":"en","type":"article","venue":"British Journal of Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"Prism Eye Institute","funders":"Novartis Pharma; Allergan; Genentech; Pfizer; Karolinska Institutet; Sanofi; Heidelberg Engineering; Alimera Sciences; Rheinische Friedrich-Wilhelms-Universität Bonn; Université de Liège; GlaxoSmithKline","keywords":"Ranibizumab; Medicine; Macular degeneration; Incidence (geometry); Retrospective cohort study; Ophthalmology; Clinical trial; Adverse effect; Observational study; Population; Safety profile; Emergency medicine; Bevacizumab; Surgery; Internal medicine; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01787028,0.0006377624,0.0016631,0.00292507,0.0002596695,0.001452212,0.0008251982,0.0007816923,0.0005899267],"category_scores_gemma":[0.02165106,0.0005296554,0.002915557,0.004696609,0.0004169018,0.0008361206,0.001212747,0.000344299,0.000169222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006148533,"about_ca_system_score_gemma":0.0007443503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002062228,"about_ca_topic_score_gemma":0.001891635,"domain_scores_codex":[0.975728,0.0119705,0.003618652,0.0047254,0.003467604,0.0004897827],"domain_scores_gemma":[0.9563802,0.007510839,0.02840586,0.004125703,0.003044137,0.0005331198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002434421,0.00006417769,0.9805531,0.0003567086,0.008759336,0.00008057981,0.0001153369,0.0004365942,0.0003096609,0.00005321786,0.0002992921,0.006537715],"study_design_scores_gemma":[0.000259023,0.0007624883,0.9919519,0.00008779058,0.004697597,0.0003121406,0.0000981106,0.0007311331,0.0002517792,0.00004149988,0.0007839478,0.00002250241],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986452,0.007237479,0.001541109,0.0000630678,0.00001603321,0.0001400085,0.003801943,0.00004112307,0.0007073164],"genre_scores_gemma":[0.9940552,0.0008443192,0.0006517767,0.00005718834,0.0000300462,0.0001229915,0.004140543,0.00001091709,0.00008697598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01787028,"threshold_uncertainty_score":0.09450829,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02813690674955842,"score_gpt":0.3263384600215737,"score_spread":0.2982015532720153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}